Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Melphalan × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic Syndromes 5 Multiple Myeloma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Hematologic Neoplasms 3 Neuroblastoma 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Hematologic Diseases 2 Venentoclax 1 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Preleukemia 1 Precancerous Conditions 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Osteosarcoma 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasms by Histologic Type 1 Neoplasms 1

Interventions

Rituximab 11 Cyclophosphamide 7 Lenalidomide 5 zanubrutinib 4 venetoclax 4 Vincristine 4 orelabrutinib 3 fludarabine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 pirtobrutinib 2 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 voruciclib 1 treosulfan 1 tislelizumab 1 prednylidene 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 glofitamab 1 deltacortene 1 cc-486 1 Stem Cell Transplantation 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡